Month: September 2011

Stock Analysts

EU Backs Bayer/JNJ’s Xarelto (BAYRY) (BMY) (JNJ) (PFE) (SNY)

September 28, 2011 0

Recently Bayer ( BAYRY ) and partner Johnson & Johnson ( JNJ ) announced that the European Committee for Medicinal Products for Human Use (CHMP) has recommended their blood-thinner (anticoagulant) Xarelto (rivaroxaban) for approval for two indications. The CHMP recommended that Xarelto be cleared in the European Union (EU) for treating deep vein thrombosis (DVT) and also for preventing recurrent DVT and pulmonary embolism (PE) after an acute DVT in adults. While DVT refers to a blood clot in a deep vein, PE refers to an obstruction in a blood vessel in the lungs, mostly because of a blood clot […]

Stock Analysts

CONSOL Sells Marcellus Royalty Interest (CNX) (D) (NBL)

September 28, 2011 0

Coal miner CONSOL Energy Inc. ( CNX ) has announced the sale of its nearly 7% royalty interest in some of Antero Resources Appalachian Corp’s Marcellus Shale assets to Antero for about $193 million in cash. The royalty interest sold comprises nearly 115,647 net acres of Marcellus Shale located in nine counties in southwestern Pennsylvania and north central West Virginia. […]

Leading Accounting Bodies Release Report Highlighting How Small and Medium-Sized Companies Can Profit From Sustainability

September 28, 2011 0

Leading Accounting Bodies Release Report Highlighting How Small and Medium-Sized Companies Can Profit From Sustainability PR Newswire LONDON, NEW YORK, and TORONTO, Sept. 28, 2011 LONDON , NEW YORK , and TORONTO , Sept. 28, 2011 /PRNewswire-USNewswire/ — The Chartered Institute of Management Accountants (CIMA), the American Institute of Certified Public Accountants (AICPA), and the Canadian Institute of Chartered Accountants (CICA) today released a comprehensive international research report underlining the growing emphasis small and medium-sized enterprises (SMEs) are placing on sustainability as it becomes increasingly crucial to business performance […]

Technicals

Bullish MACD for THOR – Tale of the Tape (THOR)

September 28, 2011 0

Thoratec Corporation ’s ( THOR ) MACD indicator has entered into bullish territory with a reading of 0.1119. The Zacks #2 Rank (“Buy”) stock increased slightly to $33.67 in morning trade. The Zacks Consensus Estimate for the year ending December 2011 has increased by 10 cents over the past two months to $1.37 per share […]

Technicals

Bearish MACD for ELY – Tale of the Tape (ELY)

September 28, 2011 0

Callaway Golf Company ’s ( ELY ) MACD indicator has entered into bearish territory with a reading of -0.0708. The Zacks #5 Rank (“Strong Sell”) stock decreased more than 3% to $5.36 in morning trade. The Zacks Consensus Estimate for the year ending December 2011 has worsened by 4 cents over the past two months to a loss of 30 cents per share […]

Stock Analysts

Yoplait’s Enticing New Flavor

September 28, 2011 0

General Mills Inc.’s ( GIS ) Yoplait recently supplemented its Yoplait Frozen Fruit & Yogurt Smoothies with a new flavor, namely Chocolate Banana, to satisfy the sweet tooth this September. Each serving of the delicious dessert will provide 130 calories as well as 50% of the required calcium for our body. The yoghurt pieces are combined with milk to make it perfect for the present day life, where having a balanced diet is difficult. […]

Economic Data

Sep 28: Favorable Durable Goods Report – Economic Highlights

September 28, 2011 0

Stocks have been gaining ground all over again recently — up almost 4% in the last three days — even as tangible positive news has been hard to come by. Optimism has been growing in recent days that the Europeans are finally moving toward a TARP-like solution to get a handle on their problems, but we have yet to see any official confirmation of those rumors and discussions. […]

Stock Analysts

AmSurg Upgraded to Outperform (AMSG)

September 28, 2011 0

Recently, we upgraded AmSurg Corporation ( AMSG ) to Outperform with a target price of $25.00. AmSurg reported EPS of 41 cents in the second quarter of fiscal 2011, in line with both the Zacks Consensus Estimate and the year-ago quarter earnings. After a sluggish fiscal 2010, mainly impacted by reimbursement issues, higher interest expenses and tax rate, AmSurg reported revenues of $188.7 million, up 7.4% from $175.7 million reported in the year-ago period […]

Stock Analysts

Medco-ESRX Assert Merger Benefits (CVS) (ESRX) (MHS) (UNH)

September 28, 2011 0

Recently, Medco Health Solutions ( MHS ) and Express Script ( ESRX ) asserted the benefits of their pending merger for patients, public as well as private purchasers before the House Judiciary Subcommittee on Intellectual Property, Competition and the Internet. Through the joint venture, both the companies intend to provide a more safe and affordable pharmaceutical coverage by making prescription drugs more reachable for senior citizens, disabled and working families. […]